...
首页> 外文期刊>American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons >Tracking of TCR-Transgenic T Cells Reveals That Multiple Mechanisms Maintain Cardiac Transplant Tolerance in Mice
【24h】

Tracking of TCR-Transgenic T Cells Reveals That Multiple Mechanisms Maintain Cardiac Transplant Tolerance in Mice

机译:跟踪TCR转基因T细胞揭示了多种机制维持小鼠心脏移植耐受性。

获取原文
获取原文并翻译 | 示例

摘要

Solid organ transplantation tolerance can be achieved following select transient immunosuppressive regimens that result in long-lasting restraint of alloimmunity without affecting responses to other antigens. Transplantation tolerance has been observed in animal models following costimulation or coreceptor blockade therapies, and in a subset of patients through induction protocols that include donor bone marrow transplantation, or following withdrawal of immunosuppression. Previous data from our lab and others have shown that proinflammatory interventions that successfully prevent the induction of transplantation tolerance in mice often fail to break tolerance once it has been stably established. This suggests that established tolerance acquires resilience to proinflammatory insults, and prompted us to investigate the mechanisms that maintain a stable state of robust tolerance. Our results demonstrate that only a triple intervention of depleting CD25(+) regulatory T cells (Tregs), blocking programmed death ligand-1 (PD-L1) signals, and transferring low numbers of alloreactive T cells was sufficient to break established tolerance. We infer from these observations that Tregs and PD-1/PD-L1 signals cooperate to preserve a low alloreactive T cell frequency to maintain tolerance. Thus, therapeutic protocols designed to induce multiple parallel mechanisms of peripheral tolerance may be necessary to achieve robust transplantation tolerance capable of maintaining one allograft for life in the clinic.
机译:在选择短暂的免疫抑制方案后,可以实现对实体器官移植的耐受性,这种方案可长期抑制同种免疫而不影响对其他抗原的反应。在共刺激或共受体阻断治疗后的动物模型中,以及通过诱导方案(包括供体骨髓移植)或撤消免疫抑制后的一部分患者中,观察到了移植耐受性。来自我们实验室和其他实验室的先前数据表明,成功稳定地建立了能够成功阻止小鼠移植耐受诱导的促炎性干预措施,常常无法打破耐受性。这表明已建立的耐受性获得了对促炎性损伤的适应力,并促使我们研究维持鲁棒耐受性稳定状态的机制。我们的研究结果表明,只有三重干预才能消除CD25(+)调节性T细胞(Tregs),阻断程序性死亡配体1(PD-L1)信号并转移少量同种反应性T细胞,这足以打破既定的耐受性。我们从这些观察结果推断,Tregs和PD-1 / PD-L1信号协同作用以保持低的变态反应性T细胞频率以维持耐受性。因此,可能需要设计用于诱导外周耐受的多种平行机制的治疗方案,以实现能够维持一种同种异体移植物在临床上寿命的稳健的移植耐受性。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号